Innovation Pharmaceuticals Inc (IPIX)

[Amatuer17]

That was not the point - it was the twist and flip flop carried by Leo.

If the P3 for B-OM need higher number of patients and needs higher cost - Leo may drop B-OM like he dropped B-ABSSI - and may move to B-UP P2b as new alternative

He has shown his liking for jumping onto new trials without taking a single product to completion

Look at market response - yawn
As market just does not believe in his big PRs

Any other company with good B-OM and possibility of BTD